12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

30 de September de 2026

The NFL made history in Brazil once again this weekend, bringing its first regular-season game to Rio de Janeiro and one of … NFL in Brazil: Kasznar Leonardos Supports Brand Protection at Historic Rio Game

4 de September de 2026

On August 27, 2026, the National Council for Advertising Self-Regulation (CONAR) approved, significant updates to the Annex “X” of the Brazilian Advertising … CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

1 de September de 2026

By means of Ordinance 07/2026, published on September 1, 2026, the BPTO has announced an increase in the monthly limit for fast-track examination … Brazil Increases the Monthly Fast-Track Examination Limit for Telecommunication Patent Applications, Including PPH

Kasznar Leonardos